Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding Cumulative Life Course Impairment in Canadian Patients With Psoriasis.

Journal of cutaneous medicine and surgery·2025
Same author

Perforating dermatosis in a young female patient receiving adalimumab biosimilar CTP-17 for chronic plaque psoriasis: A case report.

SAGE open medical case reports·2025
Same author

Development of a PsA-like presentation under anti-IL-13 therapy with tralokinumab for atopic dermatitis.

Rheumatology (Oxford, England)·2025
Same author

From north to south: exploring Italian sun-exposure habits through the "Save your skin" campaign.

European journal of dermatology : EJD·2025
Same author

Refractory Disseminated Annular Elastolytic Giant Cell Granuloma Successfully Treated With Upadacitinib: A Case Report.

International journal of dermatology·2025
Same author

Clinical and Real-World Evidence on Etanercept Biosimilar Switching: A Narrative Literature Review of Efficacy and Safety.

Advances in therapy·2025
Same journal

Psychiatric Risk in Chronic Spontaneous Urticaria: A Retrospective Cohort Study.

Acta dermato-venereologica·2026
Same journal

Erythematous Nodules and Plaques on the Neck: A Quiz.

Acta dermato-venereologica·2026
Same journal

Dupilumab in Difficult-to-treat Chronic Spontaneous Urticaria: A Real-world Multicentre Cohort Study.

Acta dermato-venereologica·2026
Same journal

Application of IL-17A Inhibitors in Psoriasis Complicated by Multiple Infections - Successful Treatment and Insights from a Case of Psoriasis with HIV and Neurosyphilis.

Acta dermato-venereologica·2026
Same journal

A Systematic Literature Review on Methotrexate Hepatotoxicity in Psoriasis Management: Preconceived Notion or Real Threat?

Acta dermato-venereologica·2026
Same journal

Standardizing Prurigo Control Assessment Globally: Linguistic Validation and Cross-cultural Adaptation of Prurigo Control Test in 18 Languages.

Acta dermato-venereologica·2026
See all related articles

Related Experiment Video

Updated: Aug 2, 2025

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.2K

The Treat-to-Target Project in Atopic Dermatitis: One Year On.

Marjolein De Bruin-Weller1, Mette Deleuran2, Tilo Biedermann3

  • 1Department of Allergology and Dermatology, UMC Utrecht, National Expertise Center for Eczema, Utrecht, The Netherlands. m.s.debruin-weller@umcutrecht.nl.

Acta Dermato-Venereologica
|April 21, 2023
PubMed
Summary
This summary is machine-generated.

New systemic treatments for atopic dermatitis (AD) are available. This review examines the current treat-to-target strategy and management algorithm for AD, considering recent therapeutic advancements and suggesting areas for improvement.

More Related Videos

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

864
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

573

Related Experiment Videos

Last Updated: Aug 2, 2025

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach
09:32

Resolving Water, Proteins, and Lipids from In Vivo Confocal Raman Spectra of Stratum Corneum through a Chemometric Approach

Published on: September 26, 2019

7.2K
Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment
12:34

Author Spotlight: Exploring ShiDuGao's Multi-Target Approach in Anus Eczema Treatment

Published on: January 12, 2024

864
Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis
03:40

Acupoint Catgut Embedding Therapy in Traditional Chinese Medicine for Managing Allergic Rhinitis

Published on: December 20, 2024

573

Area of Science:

  • Dermatology
  • Immunology
  • Pharmacology

Background:

  • Atopic dermatitis is a chronic inflammatory skin disease.
  • Recent approvals of systemic treatments have expanded therapeutic options.
  • A treat-to-target strategy and management algorithm previously guided AD care.

Purpose of the Study:

  • To review the existing treat-to-target strategy and management algorithm for atopic dermatitis.
  • To contextualize these guidelines within the evolving landscape of systemic therapies.
  • To identify areas needing refinement and future development in AD management.

Main Methods:

  • Literature review of recent systemic treatments for atopic dermatitis.
  • Analysis of the current treat-to-target strategy and management algorithm.
  • Synthesis of information to identify gaps and areas for improvement.

Main Results:

  • The therapeutic landscape for atopic dermatitis has significantly evolved with new systemic agents.
  • The existing strategy and algorithm require updates to incorporate these advancements.
  • Specific areas for refinement in patient management have been identified.

Conclusions:

  • The current treat-to-target strategy and algorithm for atopic dermatitis need adaptation.
  • Integration of newly approved systemic treatments is crucial for optimal patient outcomes.
  • Further research and guideline development are necessary to refine atopic dermatitis management.